Figure 1: Chest X-rays in 2002 (a), 2005 (b) and 2015 (c).
Surgical treatment was performed via posterolateral thoracotomy. The mass and adjacent mediastinal pleura and pericardium were totally excised. Postoperative course was uneventful. All symptoms improved immediately.
In pathologic examination, 18¥15¥7 cm, fragile, mostly encapsulated mass consisting of multiple components was evaluated. The main tumor was represented by rounded large cells with reduced amphophilic cytoplasm and large polymorphous hyperchromatic nuclei layering small pseudovascular spaces. T umor c ells r ealized a s carcely s mall network occupied by erythrocytes (Figure 3a). In the immunohistochemical examination, the tumor was diffuse positive for CD31 and CD34 while focally positive for D2-40 and CD68 and negative for actin, keratin 8/18, desmin and CD99 (Figure 3b). Some areas of the tumor consisted of uniform spindle cells with elongated wavy nuclei and pale cytoplasm. Antoni A and Antoni B areas were detected. This component was diffusely positive for S100 protein and focally positive for EMA and also grossly negative for CD31 and CD34 (Figure 3c, d). The vascular tumor component was dominant in mass. With trichrome staining, while the spindle component was rich of collagen, the epithelioid parts were not. Areas of vascular structures were rich of reticulin. Excised mediastinal pleura and pericardium were infiltrated with the tumor. Based on clinical findings and the medical history, the final pathologic diagnosis was epithelioid angiosarcoma arising from a schwannoma.
The patient was consulted to medical and radiation oncology for adjuvant therapy. Because the tumor had invaded both the adjacent pleura and the pericardium, it was not found eligible for adjuvant radiotherapy. So, the patient only received four cycles of Doxorubicin + Ifosfamide + Mesna (2500 mg/m2 Ifosfomide + 2 500 mg/m2 Mesna + 60 mg/m2 Doxorubicin) chemotherapy and follow-up tomography and also positron emission tomography/ computed tomography scan where there was no evidence of malignant tissue. On the 22nd month of follow-up, the patient was free of any signs of disease.
The pathologic pathway leading to the angiosarcoma
transformation is unclear. While some authors suggest
that the angiosarcoma arise directly from the vascular
structures of the schwannoma, some others suggest
that chronic vascular stasis and edema is the triggering
factor.
Differential diagnosis for these extremely rare
cases includes epithelioid malignant peripheral nerve
sheath tumor and the schwannoma variants; therefore,
immunohistochemistry is helpful in diagnosis. Factor VIII, CD31 and CD34 are common markers
for endothelial differentiation. The benign neural
component of the tumor was consisted of uniform
spindle cells. Presence of Antoni A and Antoni B areas
enabled differentiation from normal anatomic cells.
Malignant tumors of mediastinum are highly
challenging for the surgeon. However, it is known
that the only curative treatment of soft tissue
sarcomas is complete surgical resection. In complete
resection, capsule penetration, invasion of the
adjacent tissues and large tumor size were shown
to be related to poor prognosis.[1] On the other
hand, local tumor control can improve survival in
mediastinal sarcomas, particularly when the disease
is limited in thorax.[8] It is mostly hard to achieve
tumor free surgical margins for these types of
tumors so neoadjuvant a nd a djuvant t herapy h ad
come into scene in recent years.
In conclusion, malignant transformation in a
benign schwannoma is a rare condition, while
development of an angiosarcoma in this ground
is extremely rare. Treatment of these tumors is
controversial in the literature. The main goal of
therapy is total excision of the tumor for limited
disease in selected patients; however, if not possible,
adjuvant treatment including chemotherapy and/or
radiotherapy may be the only chance. Unfortunately,
none of these attempts seem to achieve satisfactory
overall survival rates.
Declaration of conflicting interests
Funding
The authors declared no conflicts of interest with respect to
the authorship and/or publication of this article.
The authors received no financial support for the research
and/or authorship of this article.
1) Li C, Chen Y, Zhang H, Zheng X, Wang J. Epithelioid
angiosarcoma arising in schwannoma: report of three Chinese
cases with review of the literature. Pathol Int 2012;62:500-5.
2) Occhipinti M, Heidinger BH, Franquet E, Eisenberg RL, Bankier
AA. Imaging the posterior mediastinum: a multimodality
approach. Diagn Interv Radiol 2015;21:293-306.
3) Woodruff JM, Selig AM, Crowley K, Allen PW.
Schwannoma (neurilemoma) with malignant transformation.
A rare, distinctive peripheral nerve tumor. Am J Surg Pathol
1994;18:882-95.
4) Trassard M, Le Doussal V, Bui BN, Coindre JM. Angiosarcoma
arising in a solitary schwannoma (neurilemoma) of the
sciatic nerve. Am J Surg Pathol 1996;20:1412-7.
5) Mentzel T, Katenkamp D. Intraneural angiosarcoma
and angiosarcoma arising in benign and malignant
peripheral nerve sheath tumours: clinicopathological and
immunohistochemical analysis of four cases. Histopathology
1999;35:114-20.
6) McMenamin ME, Fletcher CD. Expanding the spectrum of
malignant change in schwannomas: epithelioid malignant
change, epithelioid malignant peripheral nerve sheath tumor,
and epithelioid angiosarcoma: a study of 17 cases. Am J Surg
Pathol 2001;25:13-25.